So you know, our powers that be are working to try to see what they can do to help cover some of that cost [of GLP1s], which is something that our employees liked. Human Resource Representative, large manufacturer We were covering [GLP-1 agonists for weight loss] and they tripled our cost
The copper chelator tetrathiomolybdate, which blocks the copper-dependent catalytic activity of LOX, is presently undergoing a phase II study (NCT00195091) involving patients with breast cancer at moderate to high risk of recurrence
This vintage Jill Smoller quadrafecta was not a spontaneous confessional
White Blood Cells: Battling Blood Cells
According to Novo Nordisk's published phase III clinical trial data submitted to the FDA, participants assigned to oral Wegovy experienced average weight reduction outcomes in the low-to-mid-teens percentage range over the study period, while placebo groups demonstrated substantially lower changes
She switched to the Wegovy pill because her health insurance changed, meaning that she would go from paying $25 a month to $449 a month for Zepbound
